Cargando…

Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas

Dedifferentiated chondrosarcomas (DDCS) are highly malignant bimorphic mesenchymal tumors with poor outcome and limited treatment options. Genes and proteins involved in angiogenesis play an important role in the development of invasion and metastasis. Immunohistochemical stains targeting HSP70, pER...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoedel, Karen, Miller, Virginia, Osei-Hwedieh, David, Watters, Rebecca, Duensing, Anette, John, Ivy, Chandran, Uma, Chang, Alexander, Soman, Vishal, Weiss, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167291/
https://www.ncbi.nlm.nih.gov/pubmed/34094840
http://dx.doi.org/10.1016/j.jbo.2021.100370
_version_ 1783701664466731008
author Schoedel, Karen
Miller, Virginia
Osei-Hwedieh, David
Watters, Rebecca
Duensing, Anette
John, Ivy
Chandran, Uma
Chang, Alexander
Soman, Vishal
Weiss, Kurt
author_facet Schoedel, Karen
Miller, Virginia
Osei-Hwedieh, David
Watters, Rebecca
Duensing, Anette
John, Ivy
Chandran, Uma
Chang, Alexander
Soman, Vishal
Weiss, Kurt
author_sort Schoedel, Karen
collection PubMed
description Dedifferentiated chondrosarcomas (DDCS) are highly malignant bimorphic mesenchymal tumors with poor outcome and limited treatment options. Genes and proteins involved in angiogenesis play an important role in the development of invasion and metastasis. Immunohistochemical stains targeting HSP70, pERK1/2 and VEGFA were applied to a TMA containing 29 DDCS cases representing both tumor components. Higher expression of HSP70 and pERK1/2 was noted in the dedifferentiated component. RNA sequencing performed in 8 paired cases of DDCS comparing well differentiated and dedifferentiated components, showed higher expression of several HSP70 family members and HSP90 in the dedifferentiated component. Furthermore, high mobility group AT-hook 2 (HMAG2) and SET nuclear proto-oncogene demonstrated higher expression in the dedifferentiated component. Thus, the well differentiated and dedifferentiated components of DDCS are different, histologically and transcriptomically. The dedifferentiated component of DDCS shows higher expression of markers that are associated with malignant behavior. Some of these may represent future treatment targets.
format Online
Article
Text
id pubmed-8167291
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81672912021-06-05 Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas Schoedel, Karen Miller, Virginia Osei-Hwedieh, David Watters, Rebecca Duensing, Anette John, Ivy Chandran, Uma Chang, Alexander Soman, Vishal Weiss, Kurt J Bone Oncol Research Paper Dedifferentiated chondrosarcomas (DDCS) are highly malignant bimorphic mesenchymal tumors with poor outcome and limited treatment options. Genes and proteins involved in angiogenesis play an important role in the development of invasion and metastasis. Immunohistochemical stains targeting HSP70, pERK1/2 and VEGFA were applied to a TMA containing 29 DDCS cases representing both tumor components. Higher expression of HSP70 and pERK1/2 was noted in the dedifferentiated component. RNA sequencing performed in 8 paired cases of DDCS comparing well differentiated and dedifferentiated components, showed higher expression of several HSP70 family members and HSP90 in the dedifferentiated component. Furthermore, high mobility group AT-hook 2 (HMAG2) and SET nuclear proto-oncogene demonstrated higher expression in the dedifferentiated component. Thus, the well differentiated and dedifferentiated components of DDCS are different, histologically and transcriptomically. The dedifferentiated component of DDCS shows higher expression of markers that are associated with malignant behavior. Some of these may represent future treatment targets. Elsevier 2021-05-18 /pmc/articles/PMC8167291/ /pubmed/34094840 http://dx.doi.org/10.1016/j.jbo.2021.100370 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Schoedel, Karen
Miller, Virginia
Osei-Hwedieh, David
Watters, Rebecca
Duensing, Anette
John, Ivy
Chandran, Uma
Chang, Alexander
Soman, Vishal
Weiss, Kurt
Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas
title Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas
title_full Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas
title_fullStr Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas
title_full_unstemmed Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas
title_short Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas
title_sort differential expression of angiogenesis markers hsp70, hsp90, vegf and perk1/2 in both components of dedifferentiated chondrosarcomas
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167291/
https://www.ncbi.nlm.nih.gov/pubmed/34094840
http://dx.doi.org/10.1016/j.jbo.2021.100370
work_keys_str_mv AT schoedelkaren differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas
AT millervirginia differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas
AT oseihwediehdavid differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas
AT wattersrebecca differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas
AT duensinganette differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas
AT johnivy differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas
AT chandranuma differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas
AT changalexander differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas
AT somanvishal differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas
AT weisskurt differentialexpressionofangiogenesismarkershsp70hsp90vegfandperk12inbothcomponentsofdedifferentiatedchondrosarcomas